Document is current
Any future updates will be listed below
-
Authors
Matt, Michael G.
Fuehner, Sabrina
Do, Thuy
Schleifenbaum, Susanne
Chiang, Samuel
Marsh, Rebecca
Wouters, Carine
Matthys, Patrick
Gouwy, Mieke
Foell, Dirk
Hinze, Claas
Canna, Scott
Caiello, Ivan
Prencipe, Giusi
Bracaglia, Claudia
De Benedetti, Fabrizio
Dissanayake, Dilan
Goh, Y. Ingrid
Hamann, Dorte
Scholman, Rianne
Vastert, Sebastiaan
Brown, Kelly L.
Cabral, David A.
Schulert, Grant
Kessel, Christoph
,
-
Funding
Funding for this research was provided by:
Childhood Arthritis and Rheumatology Research Alliance
Pediatric Rheumatology European Society
- License Information
-
More Information
Article History
Received: 10 December 2025
Accepted: 24 April 2026
First Online: 9 May 2026
Declarations
:
: CARRA Registry enrollment and biosample collection were approved by the IRB (DCRI Reliant IRB (WCG) and/or IRB at all Registry sites, and CCHMC 2020 − 0146). This study was performed in accordance with the Declaration of Helsinki and all patients or parents/guardians provided informed consent for both Registry enrollment and biosample collection.
: Not applicable.
: CK has received consulting fees from Novartis and Swedish Orphan Biovitrum (SOBI) and received research support from Novartis. GS has received consulting fees from SOBI and Novartis, and research support from IpiNovyx. BV has received consultancy fees from Sobi and Novartis, as well as an unrestricted research grant from Sobi in a public-private grant mechanism. CW has been an iDMC member for SOBI, has received speakers’ fee from SOBI, and has received speakers’ fee from Novartis. CB has received consulting fees from Sobi and Novartis, as well as speaking fees from GSK. RAM is employed part-time by Pharming Healthcare, Warren, NJ, and has performed consulting for AB2Bio. CK is Senior Editor of Pediatric Rheumatology, GS is Associate Editor of Pediatric Rheumatology, and CB, FdB, BV, and DD are members of the journal’s editorial board.
